Cathepsin K-upregulation in fibroblasts promotes matrigel invasive ability of squamous cell carcinoma cells via tumor-derived IL-1α

Journal of Dermatological Science

Volumn 61, Issue 1, 2011, Pages 45-50

  Xie, Lining ^a   Moroi, Yoichi ^a   Hayashida, Sayaka ^a   Tsuji, Gaku ^a   Takeuchi, Satoshi ^a   Shan, Baoen ^b   Nakahara, Takeshi ^a   Uchi, Hiroshi ^a,c   Takahara, Masakazu ^a   Furue, Masutaka ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cathepsin K; IL 1 ; Matrigel invasion assay; Squamous cell carcinoma

Indexed keywords

CATHEPSIN K; INTERLEUKIN 1ALPHA; NEUTRALIZING ANTIBODY;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOMA CELL; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CATHEPSIN K; COCULTURE TECHNIQUES; COLLAGEN; DRUG COMBINATIONS; FIBROBLASTS; HUMANS; INTERLEUKIN-1ALPHA; KERATINOCYTES; LAMININ; PROTEOGLYCANS; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 78650679889     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.09.005     Document Type: Article

References (24)

1. Lorusso G., Rüegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 2008, 130:1091-1103.
2. Hanna E., Quick J., Libutti S.K. The tumour microenvironment: a novel target for cancer therapy. Oral Dis 2009, 15:8-17.
3. Nielsen J.D., Moeslund M., Wandall H.H., Dabelsteen S. Influences of tumor stroma on the malignant phenotype. J Oral Pathol Med 2008, 37:412-416.
4. Fidler I.J. The Ernst W Bertner Memorial Award lecture: the evolution of biological heterogeneity in metastatic neoplasms. Symp Fundam Cancer Res 1983, 36:5-26.
5. Hart I.R. 'Seed and soil' revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev 1982, 1:5-16.
6. Johansson N., Ahonen M., Kähäri V.M. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000, 57:5-15.
7. Drake F.H., Dodds R.A., James I.E., Connor J.R., Debouck C., Richardson S., et al. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 1996, 271:12511-12516.
8. Arnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352.
9. Husmann K., Muff R., Bolander M.E., Sarkar G., Born W., Fuchs B. Cathepsins and osteosarcoma: expression analysis identifies cathepsin K as an indicator of metastasis. Mol Carcinog 2008, 47:66-73.
10. Kleer C.G., Bloushtain-Qimron N., Chen Y.H., Carrasco D., Hu M., Yao J., et al. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res 2008, 14:5357-5367.
11. Rapa I., Volante M., Cappia S., Rosas R., Scagliotti G.V., Papotti M. Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not bronchioloalveolar carcinoma. A useful marker of invasive growth. Am J Clin Pathol 2006, 125:847-854.
12. Quintanilla-Dieck M.J., Codriansky K., Keady M., Bhawan J., Rünger T.M. Cathepsin K in melanoma invasion. J Invest Dermatol 2008, 128:2281-2288.
13. Xie L., Hayashida S., Yan X., Tsuji G., Nakahara T., Takeuchi S., et al. Overexpression of stromal cathepsin K expression correlates with invasiveness of extramammary Paget's disease. Eur J Dermatol 2010, 20:415-416.
14. Yan X., Takahara M., Xie L., Oda Y., Nakahara T., Uchi H., et al. Stromal expression of cathepsin K in squamous cell carcinoma. J Eur Acad Dermatol Venereol 2010, [epub ahead of print].
15. Quintanilla-Dieck M.J., Codriansky K., Keady M., Bhawan J., Rünger T.M. Expression and regulation of cathepsin K in skin fibroblasts. Exp Dermatol 2009, 18:596-602.
16. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47:3239-3245.
17. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
18. Jedeszko C., Sloane B.F. Cysteine cathepsins in human cancer. Biol Chem 2004, 385:1017-1027.
19. Mohamed M.M., Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006, 6:764-775.
20. Bell-McGuinn K.M., Garfall A.L., Bogyo M., Hanahan D., Joyce J.A. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer. Cancer Res 2007, 67:7378-7385.
21. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352.
22. Tanjore H., Kalluri R. The role of type IV collagen and basement membranes in cancer progression and metastasis. Am J Pathol 2006, 168:715-717.
23. Matsuo Y., Sawai H., Ma J., Xu D., Ochi N., Yasuda A., et al. IL-1alpha secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1alpha release and tumor cells' potential for liver metastasis. J Surg Oncol 2009, 99:361-367.
24. Graziano F., Ruzzo A., Canestrari E., Loupakis F., Santini D., Rulli E., et al. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. Pharmacogenomics J 2009, 9:78-84.